强生公司与美国政府达成1亿剂新冠疫苗产销协议_老虎社区_美港股上老虎

强生公司与美国政府达成1亿剂新冠疫苗产销协议

新浪财经综合2020-08-06

美国强生公司（Johnson&Johnson）与美国政府达成价值超过10亿美元1亿剂新冠疫苗生产和交付协议。美国强生公司在其官网发布消息说：“强生公司宣布，旗下杨森制药公司已与美国政府达成协议，将在美国大规模生产和交付1亿剂杨森制药研发的SARS-CoV-2试验疫苗”。强生公司在消息中指出，美国生物医学高级研究与发展局（BARDA）与美国国防部将为落实这一协议投入超过10亿美元。美国强生公司...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2057497366?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/7cc1111a7669a23daf039d019dcde62d","is_english":false,"pubTime":"2020-08-06 07:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2057497366","market":"us","top_or_hot":-1,"title":"强生公司与美国政府达成1亿剂新冠疫苗产销协议","media":"新浪财经综合","content":"<div>\n<p>美国强生公司（Johnson&Johnson）与美国政府达成价值超过10亿美元1亿剂新冠疫苗生产和交付协议。\n美国强生公司在其官网发布消息说：“强生公司宣布，旗下杨森制药公司已与美国政府达成协议，将在美国大规模生产和交付1亿剂杨森制药研发的SARS-CoV-2试验疫苗”。\n强生公司在消息中指出，美国生物医学高级研究与发展局（BARDA）与美国国防部将为落实这一协议投入超过10亿美元。\n美国强生公司...</p>\n\n<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-08-06/doc-iivhvpwx9437127.shtml\">网页链接</a>\n\n</div>\n","source":"sina_symbol","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>强生公司与美国政府达成1亿剂新冠疫苗产销协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n强生公司与美国政府达成1亿剂新冠疫苗产销协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-08-06 07:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-08-06/doc-iivhvpwx9437127.shtml><strong>新浪财经综合</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国强生公司（Johnson&Johnson）与美国政府达成价值超过10亿美元1亿剂新冠疫苗生产和交付协议。\n美国强生公司在其官网发布消息说：“强生公司宣布，旗下杨森制药公司已与美国政府达成协议，将在美国大规模生产和交付1亿剂杨森制药研发的SARS-CoV-2试验疫苗”。\n强生公司在消息中指出，美国生物医学高级研究与发展局（BARDA）与美国国防部将为落实这一协议投入超过10亿美元。\n美国强生公司...</p>\n\n<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-08-06/doc-iivhvpwx9437127.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FMN","symbol_name":"FMN市政收益基金","start_time":0,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-08-06/doc-iivhvpwx9437127.shtml","article_id":"2057497366","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/7cc1111a7669a23daf039d019dcde62d"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-08-06/doc-iivhvpwx9437127.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2057497366","pubTimestamp":1596669266,"sourceInfo":{"source_id":"sina_symbol","name":"新浪媒体新闻"},"weMediaInfo":null,"summary":"美国强生公司（Johnson&Johnson）与美国政府达成价值超过10亿美元1亿剂新冠疫苗生产和交付协议。\n美国强生公司在其官网发布消息说：“强生公司宣布，旗下杨森制药公司已与美国政府达成协议，将在","collect":0,"end_time":0,"defaultTopTitle":"sina.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"FMN":"FMN市政收益基金","WVE":"Wave Life Sciences Pte. Ltd","VVPR":"VivoPower","ENLV":"Enlivex Therapeutics Ltd.","MKL":"Markel Corp","LPCN":"Lipocine Inc","TVTY":"Tivity Health, Inc.","BTAI":"Bioxcel Therapeutics Inc.","GJR":"STRATS Trust for Procter & Gamble 2006-1","COCP":"Cocrystal Pharma, Inc.","CARG":"Cargurus Inc.","EVLO":"Evelo Biosciences","ENBL":"Enable Midstream Partners LP Common Units representing limited","RVMD":"Revolution Medicines, Inc.","LMPX":"LMP Automotive Holdings, Inc.","XAIR":"BEYOND AIR INC","AR":"Antero Resources Corp","TOPS":"TOP Ships Inc","UBSBF":"Kure Technologies, Inc. ","GNPX":"Genprex, Inc.","JNJ":"强生"},"translate_title":"Johnson & Johnson reaches deal with U.S. government to produce and sell 100 million doses of COVID-19 vaccine","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/3ba0a3565b8883d9a1ee9a33704423ec","symbols_score_info":{"IORG":0.9,"XAIR":0.9,"WVE":0.9,"VVPR":0.9,"TVTY":0.9,"TOPS":0.9,"SFET":0.9,"RVMD":0.9,"NVIV":0.9,"NTEC":0.9,"MKL":0.9,"LPCN":0.9,"LMPX":0.9,"JNJ":0.9,"AFMCF":0.9,"GNPX":0.9,"GJR":0.9,"FMN":0.9,"EVLO":0.9,"ENLV":0.9,"ENBL":0.9,"COCP":0.9,"CGNGY":0.9,"CDEV":0.9,"CARG":0.9,"BTAI":0.9,"AXHLF":0.9,"AR":0.9,"APOP":0.9,"UBSBF":0.6},"content_text":"美国强生公司（Johnson&Johnson）与美国政府达成价值超过10亿美元1亿剂新冠疫苗生产和交付协议。\n美国强生公司在其官网发布消息说：“强生公司宣布，旗下杨森制药公司已与美国政府达成协议，将在美国大规模生产和交付1亿剂杨森制药研发的SARS-CoV-2试验疫苗”。\n强生公司在消息中指出，美国生物医学高级研究与发展局（BARDA）与美国国防部将为落实这一协议投入超过10亿美元。\n美国强生公司此前宣布，预计将在2021年初生产出第一批疫苗。强生公司首席科学官保罗·斯托弗尔斯博士表示，第一批疫苗应该足够全球医护人员接种之用。公司计划最终生产超过10亿剂疫苗。\n世界卫生组织3月11日将COVID-19疫情定性为大流行。该组织最新数据显示，全球累计感染病例超1800万例，超69.1万人死亡。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}